Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

349
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
349
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

902
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
902

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hyaluronic acid: biological functions, production strategies, and clinical applications.

In vitro models·2026
Same author

Aptamer-based biosensing strategies for influenza virus detection: a systematic and critical review of electrochemical and optical platforms.

Critical reviews in clinical laboratory sciences·2026
Same author

Epirubicin-Induced Upregulation of miR-143-3p and miR-145 Enhances Cytotoxicity in MCF-7, MDA-MB-231, and BT-474 Breast Cancer Cell Lines.

Biochemical genetics·2026
Same author

Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer.

Clinical and experimental medicine·2026
Same author

Exploring the pathogenesis of a compound heterozygous variant in ATP7B associated with Wilson disease in an Iranian family.

Molecular biology reports·2026
Same author

In vitro and in silico analysis of three variants associated with type 2 diabetes.

Acta diabetologica·2026

相关实验视频

Updated: Sep 15, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K

初级渐进性多发性硬化症:新的治疗方法

Morteza Rajabi1, Sajjad Shafaeibajestan2, Sevda Asadpour3

  • 1Department of Genetics, Faculty of Basic Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran.

Neuropsychopharmacology reports
|July 13, 2025
PubMed
概括

初级渐进性多发性硬化症 (PPMS) 的治疗具有挑战性. 新兴疗法如ocrelizumab和人类胎儿神经前体细胞 (hfNPCs) 在临床试验中显示出神经保护和减缓疾病进展的前途.

关键词:
这就是fingolimod的意思.基因治疗的基因疗法通过神经调节进行神经调节.这就是Ocrelizumab.原发性进展性多发性硬化症.干细胞疗法是一种干细胞疗法.

更多相关视频

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.4K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K

相关实验视频

Last Updated: Sep 15, 2025

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.4K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

17.8K

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 再生医学是一种再生医学.

背景情况:

  • 初级渐进性多发性硬化症 (PPMS) 是一种独特的MS形式,其特征是逐渐,不可逆转的神经衰退.
  • 影响10-15%的MS患者,PPMS带来了独特的诊断和治疗挑战.
  • 症状包括渐进的移动性问题,疼痛,感官和认知缺陷以及自主功能障碍.

研究的目的:

  • 对初级渐进性多发性硬化症的当前和新兴治疗策略进行审查.
  • 评估新的治疗方法的潜力,包括基于细胞的疗法和基因疗法.

主要方法:

  • 对PPMS治疗方法的现有文献的审查.
  • 对正在进行的临床试验和临床前研究进行分析.
  • 评估新兴疗法,如ocrelizumab,干细胞疗法和基因疗法.

主要成果:

  • 奥克雷利祖马布在减少PPMS进展方面表现出有效性.
  • 研究中的药物 (生物素,simvastatin,辅酶Q10) 和治疗方法 (fingolimod,idebenone,anti-LINGO-1,神经调节,等离子酶) 正在研究中.
  • 临床前的基因疗法和干细胞研究显示了神经保护,复髓化和免疫调节的潜力.

结论:

  • 人类胎儿神经前体细胞 (hfNPCs) 提供神经保护性益处和PPMS治疗的潜力.
  • 对hfNPCs的早期临床试验显示出有希望的结果,需要进一步调查其安全性和有效性.
  • 持续的研究对于开发有效的PPMS治疗方法至关重要.